Lithium sulfate

硫酸锂

Report date: 2026/03/30 17:02:26

Base Information

Drug NameLithium sulfate
Drug Alias NameLithiofor
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsBipolar Disorder
Global Approved IndicationsBipolar Disorder
Approved Indications in ChinaN/A
Original Approved Country/TerritoryItaly
Original Approved Date2016/03/16
Country/TerritoryItaly
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVifor France
China Registration ClassN/A

Develop Information

Active CompaniesVifor France Sa
Inactive CompaniesN/A
Active IndicationsBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A